Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis. E Hajdarbegovic, DM Balak The New England journal of medicine 376 (21), 2092, 2017 | 619* | 2017 |
A benchmark for comparison of cell tracking algorithms M Maška, V Ulman, D Svoboda, P Matula, P Matula, C Ederra, A Urbiola, ... Bioinformatics 30 (11), 1609-1617, 2014 | 495 | 2014 |
Drug-induced psoriasis: clinical perspectives DMW Balak, E Hajdarbegovic Psoriasis (Auckland, NZ) 7, 87, 2017 | 163 | 2017 |
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis DS Bakker, LFM Ariens, C van Luijk, J van der Schaft, JL Thijs, ... British Journal of Dermatology, 2018 | 130 | 2018 |
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe … DMW Balak, MBA van Doorn, RD Arbeit, R Rijneveld, E Klaassen, ... Clinical Immunology 174, 63-72, 2017 | 99 | 2017 |
In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine M Xu, J Deng, K Xu, T Zhu, L Han, Y Yan, D Yao, H Deng, D Wang, Y Sun, ... THERANOSTICS 9 (9), 2475-2488, 2019 | 94 | 2019 |
Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review DMW Balak, GJD Hengstman, A Çakmak, HB Thio Multiple Sclerosis Journal 18 (12), 1705-1717, 2012 | 82 | 2012 |
Long-term safety of oral systemic therapies for psoriasis: a comprehensive review of the literature DMW Balak, S Gerdes, A Parodi, L Salgado-Boquete Dermatology and Therapy 10 (4), 589-613, 2020 | 75 | 2020 |
Fumaric acid esters in the management of psoriasis DMW Balak Psoriasis Targets Ther 5, 9-23, 2015 | 61 | 2015 |
Tissue‐resident memory CD8+ T cells from skin differentiate psoriatic arthritis from psoriasis EF Leijten, TS van Kempen, MA Olde Nordkamp, JN Pouw, ... Arthritis & Rheumatology, 0 | 61 | |
Refinement of the genetic cause of ATR-16 CL Harteveld, M Kriek, EK Bijlsma, Z Erjavec, D Balak, M Phylipsen, ... Human genetics 122 (3-4), 283-292, 2007 | 46 | 2007 |
Efficacy, effectiveness and safety of fumaric acid esters in the treatment of psoriasis: a systematic review of randomized and observational studies DMW Balak, S Fallah Arani, E Hajdarbegovic, CAF Hagemans, ... British Journal of Dermatology 175 (2), 250-262, 2016 | 43 | 2016 |
Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands DMW Balak, AM Oostveen, MT Bousema, AW Venema, WP Arnold, ... British Journal of Dermatology 168 (6), 1343-1347, 2013 | 42 | 2013 |
Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis R Achten, D Bakker, L Ariens, A Lans, J Thijs, J van der Schaft, J de Boer, ... The Journal of Allergy and Clinical Immunology: In Practice, 2020 | 37 | 2020 |
Regulated genes in psoriatic skin during treatment with fumaric acid esters AJ Onderdijk, DMW Balak, EM Baerveldt, EF Florencia, M Kant, JD Laman, ... British Journal of Dermatology 171 (4), 732-741, 2014 | 37 | 2014 |
Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study R Lijnen, E Otters, D Balak, B Thio Journal of Dermatological Treatment 27 (1), 31-36, 2016 | 36 | 2016 |
Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the Netherlands DMW Balak, SC Gouw, I Plug, EP MAUSER‐BUNSCHOTEN, A Vriends, ... Haemophilia 18 (4), 584-592, 2012 | 31 | 2012 |
Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the Netherlands DMW Balak, SC Gouw, I Plug, EP Mauser-Bunschoten, A Vriends, ... HAEMOPHILIA 17 (2), 367-368, 2011 | 31 | 2011 |
Highlights of the updated Dutch evidence-and consensus-based guideline on psoriasis 2017. GE van der Kraaij, DMW Balak, CI Busard, OD van Cranenburgh, ... The British journal of dermatology 180 (1), 31, 2019 | 28 | 2019 |
Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies DMW Balak, S Piaserico, I Kasujee Psoriasis: Targets and Therapy 11, 151, 2021 | 27 | 2021 |